BAT mediates nonshivering thermogenesis in mammals that are exposed to temperatures below thermoneutrality, an ambient environment in which basal metabolism is sufficient to maintain body temperature 1 . To sustain its exceptional oxidative metabolic activity, BAT consumes vast amounts of intracellular and circulating nutrients 2 , and in doing so, BAT activity exerts beneficial metabolic effects on obesity 2 , insulin resistance 3 and atherosclerosis 4, 5 . During cold acclimatization BAT undergoes an adaptive recruitment process, and the tissue grows in size and in total metabolic capacity. This involves both new adipocyte differentiation, as well as increased metabolic activity of existing adipocytes 1, [6] [7] [8] . BAT is also activated by acute nutrient influx, in particular by consumption of a high-fat diet (HFD) 9,10 , but the chronic exposure to excess nutrients that occurs in obesity results in whitening and reduced metabolic capacity of BAT in mice 11 and humans 12, 13 .
BAT mediates nonshivering thermogenesis in mammals that are exposed to temperatures below thermoneutrality, an ambient environment in which basal metabolism is sufficient to maintain body temperature 1 . To sustain its exceptional oxidative metabolic activity, BAT consumes vast amounts of intracellular and circulating nutrients 2 , and in doing so, BAT activity exerts beneficial metabolic effects on obesity 2 , insulin resistance 3 and atherosclerosis 4, 5 . During cold acclimatization BAT undergoes an adaptive recruitment process, and the tissue grows in size and in total metabolic capacity. This involves both new adipocyte differentiation, as well as increased metabolic activity of existing adipocytes 1, [6] [7] [8] . BAT is also activated by acute nutrient influx, in particular by consumption of a high-fat diet (HFD) 9, 10 , but the chronic exposure to excess nutrients that occurs in obesity results in whitening and reduced metabolic capacity of BAT in mice 11 and humans 12, 13 .
Because the mechanisms underlying BAT deterioration in obesity remain insufficiently understood, the identification of factors that protect thermogenic adipocytes from metabolic stress during adaptation to cold or to obesity may hold great potential toward therapeutic approaches for metabolic diseases. The dramatic metabolic changes in BAT not only involve dissipation of energy-rich nutrients but also the de novo synthesis of new proteins, lipids and cellular organelles 1 . Thus, we hypothesized that cold adaptation might require adaptive mechanisms for increased quality control of these metabolic processes. In particular, enhanced protein production and folding, as well as protection against aberrantly modified or oxidized proteins and other metabolites may require adipocytespecific adaptive mechanisms to resist the rising cellular stress. The concept of specialized molecules and adaptive responses to achieve this challenging task is even more compelling in brown adipocytes, considering the unique cellular organization of high mitochondrial and lipid content and extremely high metabolic flux, yet relatively scarce levels of ER content.
As the site of protein and lipid synthesis, the ER is a critical organelle for the maintenance of metabolic and homeostatic balance. Perturbations of ER function are combated by the unfolded-protein response (UPR), a molecular network that results in enhanced protein folding capacity and decreased protein translation, as well as by ERassociated protein degradation (ERAD) of damaged or dispensable proteins via the ubiquitin-proteasome system (UPS) [14] [15] [16] [17] [18] . Obesity is associated with failure of the UPR or the ERAD pathway to secure ER function, especially in metabolically active tissues such as the liver, which results in activation of ER-and inflammatory-stress pathways and ultimately leads to the disruption of systemic metabolic homeostasis 19, 20 . However, the identity of the factors that support ER homeo stasis and promote metabolic function in adipocytes, particularly in thermogenic adipocytes, remains unclear. In light of the unique features of the ER in brown adipocytes, such as the apparently lower ER content and relatively limited ER surface area as compared to, for example, hepatocytes 21, 22 , ER adaptation in these cells may require pathways other than chaperone-mediated protein folding and ER expansion. Indeed, some of the canonical UPR molecules, such as Xbox binding protein 1 (Xbp1), seem to be dispensable in adipocytes 23 . Although the physiological significance of ERAD in brown adipocytes remains unknown, we considered proteasomal protein quality control as a possible alternative pathway by which these cells might secure ER homeostasis and their metabolic function. Here we show that proteasomal protein quality control in brown adipocytes is essential for the thermogenic adaptation of BAT and identify Nrf1 (encoded by Nfe2l1), an ER membrane-embedded transcription factor 24 , as a fundamental regulator of the adaptation of BAT to increased metabolic stress in cold or in obesity through the function of the proteasome.
RESULTS

Nonshivering thermogenesis requires proteasomal activity
The ER is a critical organelle for coordinating cellular homeostasis during states of high metabolism, but the specific pathways and ERresident proteins that contribute to the adaptation of BAT to a cold environment remain elusive. Consistent with previous results 23 , we did not find differences in thermogenic energy expenditure stimulated by CL316,243 (CL), an adipocyte-specific β3-adrenergic agonist 25 , in mice with either an adipocyte-specific inositol-requiring enzyme 1α (Ire1-α; encoded by Ern1) or an Xbp1 deficiency ( Supplementary  Fig. 1a,b) , indicating that this branch of the UPR was dispensable for BAT-mediated respiration.
Because ERAD supports ER function by removing damaged or dispensable proteins 14, 15 , we focused on protein degradation through the UPS as a potential alternate mechanism by which brown adipocytes secure ER homeostasis and ameliorate metabolic stress. To investigate whether cold adaptation was linked to proteasome function, we first measured proteasomal activity in BAT from wild-type (WT) mice that had been adapted to thermoneutrality (30 °C), room temperature (22 °C) or cold (4 °C) for 7 d. We found that cold adaptation to either 22 °C or 4 °C was associated with higher proteasomal activity in BAT, as compared to that after adaptation to 30 °C (Fig. 1a) . In contrast, proteasomal activity remained unchanged after cold adaptation in the liver (Supplementary Fig. 1c) . To determine the physiological significance of this observation for nonshivering thermogenesis, we treated mice housed at 30 °C or 22 °C with bortezomib, a clinical proteasome inhibitor 26, 27 . We observed that at 22 °C, a setting in which nonshivering thermogenesis in BAT is active, mice treated with bortezomib were less able to defend their core body temperature as compared to control mice treated with dimethyl sulfoxide (DMSO), whereas mice that had been adapted to 30 °C and treated with bortezomib or DMSO showed no difference in their ability to defend core body temperature (Fig. 1b) . These data demonstrated that proteasome function is critically important for sustaining nonshivering thermogenesis. This effect was independent of changes in the mRNA expression of the genes that coded for uncoupling protein 1 (Ucp1) or peroxisome proliferator receptor-γ, co-activator 1-α (Pgc1-α, encoded by Ppargc1a) (Fig. 1c) or in the amount or histological appearance of BAT (Supplementary Fig. 1d ).
Proteasomal activity promotes ER homeostasis in BAT
In the BAT of mice housed at 22 °C, bortezomib treatment led to higher mRNA expression of markers of stress pathway activationsuch as heat shock protein 5 (Hspa5; which encodes a product also known as GRP78 or BiP), DNA-damage-inducible transcript 3 (Ddit3; which encodes a product also known as Chop), spliced Xbp1 (Xbp1s), activating transcription factor 4 (Atf4) and Cd68 antigen (Cd68)-as compared to that in DMSO-treated controls, whereas in the BAT of mice housed at 30 °C, this response was diminished (Fig. 1c) , indicating that proteasome function was also required to limit cellular stress in BAT, particularly in states of high metabolism. In contrast, housing at 30 °C did not abrogate the effect of proteasome inhibition on stress pathway activation in the livers of these mice ( Supplementary  Fig. 1e ). Because bortezomib may have off-target protease inhibitor effects 28 , we additionally evaluated the effects of carfilzomib, a potent, structurally distinct and specific proteasome inhibitor in clinical use 28 . Treatment with carfilzomib produced findings similar to those of bortezomib, as both proteasome inhibitors led to lower body temperature and higher ER stress, as compared to that in DMSOtreated control mice, only when the mice were under thermal stress but not at 30 °C (Supplementary Fig. 1f,g ).
In adipocytes that expressed a reporter system for ER function 29 , we found that proteasome inhibition by bortezomib or epoxomicin resulted in a similar degree of impairment in ER function as treatment with thapsigargin, a known inducer of ER stress 30 ( Supplementary  Fig. 2a) , an observation that supported the idea of a critical role for the proteasome in maintaining ER function in adipocytes. To explore whether proteasome function might be specifically required for brown adipocyte respiration, we directly tested the effect of proteasome inhibition on mitochondrial bioenergetics. Notably, ADP-stimulated (state 3), carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP)-induced (maximal capacity) and GDP-sensitive (Ucp1-mediated) respiration were all lower in mitochondria isolated from the BAT of bortezomib-treated mice as compared to that in mitochondria isolated from the BAT of DMSO-treated control mice ( Supplementary  Fig. 2b,c) . Also, in a brown adipocyte cell line, treatment with epoxomicin led to lower maximal mitochondrial respiration ( Supplementary Fig. 2d-f) , which highlighted the importance of proteasomal activity for brown adipocyte oxidative capacity.
Nrf1 is highly expressed in BAT and induced by cold Recent in vitro studies have described Nrf1 to be an adaptive stimulator of proteasomal activity because of its ability to bind to the promoters of genes that encode proteasomal subunits and drive their expression 27, [31] [32] [33] . We, therefore, investigated the potential role of Nrf1 in cold-induced proteasomal activity in BAT. First, we examined the regulation of Nrf1 in human and mouse BAT and in cultured brown adipocytes. In human primary differentiated brown adipocytes, NFE2L1 mRNA was highly expressed, at substantially higher levels than those of other members of the NFE2L family (Fig. 2a) .
In human adipose tissue biopsies from subcutaneous and carotid sheath areas 34 , we found that NFE2L1 mRNA levels strongly correlated with the brown fat character of the samples (Fig. 2b) . We also analyzed a broad array of clonal cell lines derived from human adipose tissue 34 and found that NFE2L1 gene expression was a predictor of thermogenic competency (Fig. 2c) . Consistent with previous work in cultured cells 27, 31, 32 , we found that in the BAT of mice treated with either bortezomib or carfilzomib, Nrf1 expression was induced at the protein but not the mRNA level ( Fig. 2d and Supplementary Fig. 2g ), which demonstrates a functional relationship between Nrf1 and proteasomal activity in BAT. Furthermore, we generated a mouse brown adipocyte cell line in which Nrf1 was overexpressed (Supplementary Fig. 2h ) and found that it had higher proteasomal activity as compared to that in control-virus-infected cells (Fig. 2e) . Taken together, our results suggest and Nfe2l1 mRNA levels (n = 8 for DMSO; n = 7 for bortezomib) (right) in BAT after 16 h of bortezomib (2.5 mg/kg) or DMSO treatment of mice that were housed at 22 °C. For quantification of mRNA levels, data were normalized by ∆C t values and are presented as mean ± s.e.m. β-tubulin was used as a loading control in the immunoblot. (e) Proteasomal activity in Nrf1-overexpressing and control brown adipocytes (n = 3 technical replicates). (f,g) Nfe2l1 mRNA levels (n = 4 mice per group) (f) and representative immunoblot (left) and quantification (right) of Nrf1 expression (n = 3 mice per group) (g) in BAT from WT mice or mice lacking Nrf1 in brown adipocytes (Nfe2l1 ∆BAT ) after 7 d of adaptation to 4 °C. In f, expression was normalized to levels of the housekeeping gene Tata-box binding protein (Tbp). In g, lysate from Nfe2l1 −/− mouse embryonic fibroblasts (MEF) was used to confirm the specificity of the Nrf1-specific antibody, and β-tubulin was used as a loading control. (h) mRNA expression levels of the indicated genes (normalized to Tbp expression) in the BAT of WT or Nfe2l1 ∆BAT mice adapted to 4 °C or 30 °C (n = 6 mice per group). (i) mRNA levels of the indicated genes (normalized to the levels of Rn18s, which encodes the 18S rRNA) in the BAT of WT or Nfe2l1 ∆BAT mice that were housed at 22 °C after 16 h of bortezomib (2.5 mg/kg) or DMSO treatment (n = 4 mice per group). (j) mRNA levels of genes encoding stress markers in the BAT of WT or Nfe2l1 ∆BAT mice that were adapted to 4 °C or 30 °C (n = 6 mice per group). Expression was normalized to the Tbp mRNA levels. (k) Effect of bortezomib (1.25 mg per kg body weight (mg/kg)) or DMSO treatment in whole-body oxygen consumption in WT or Nfe2l1 ∆BAT mice that were housed at 22 °C (n = 8 mice per group). Throughout, data are mean ± s.e.m. *P < 0.05 by t-test (e) or two-way ANOVA (f-k).
that Nrf1 has a key role in regulating adaptive proteasomal activity in brown adipocytes in vitro and in vivo. In mice there was more Nfe2l1 mRNA in BAT than in white adipose tissue (WAT) ( Supplementary  Fig. 2i ). As compared to that at 30 °C, cold adaptation led to markedly higher Nfe2l1 expression in BAT and, to a minor extent, also in inguinal WAT (IngWAT) (Supplementary Fig. 2i ), an adipose depot prone to beige adipocyte formation and browning [35] [36] [37] .
Nrf1 drives cold-inducible proteasomal activity in BAT To evaluate the significance of cold-induced Nrf1 for proteasomal activity and thermogenic function of BAT, we generated a mouse model in which the Nfe2l1 gene was disrupted specifically in all Ucp1-expressing adipocytes, such as in BAT and IngWAT (hereafter referred to as Nfe2l1 ∆BAT mice) (Supplementary Fig. 3a ). In this model, after cold adaptation, Nfe2l1 mRNA and Nrf1 protein in BAT were markedly lower than in the WT controls (Fig. 2f,g) , showing that the induction of Nrf1 in BAT by exposure to cold takes place in brown adipocytes. Of note, we also observed that in WT mice at 30 °C, Nrf1 expression in BAT was very low as compared to that in WT mice at 4 °C (Fig. 2f,g ), suggesting that thermoneutrality is a state of natural Nrf1 deficiency. Notably, we observed that as compared to that at 30 °C, cold adaptation led to higher levels of both the ER-localized form of Nrf1 protein, as well as the cleaved, transcriptionally active form in BAT ( Supplementary Fig. 3b,c) .
In support of our hypothesis that Nrf1 is an important physiological regulator of proteasomal activity in BAT, cold adaptation led to higher mRNA expression of genes encoding proteasomal subunits (Psma1, Psmb1 and Psmd1) as compared to that at 30 °C in WT mice but not in Nfe2l1 ∆BAT mice (Fig. 2h) . In addition, treatment with bortezomib led to higher expression of genes encoding proteasomal subunits in the BAT of WT controls; however, this induction was blunted in the BAT of Nfe2l1 ∆BAT mice (Fig. 2i) , whereas the Nrf1-proteasome pathway was still functional in the livers of these mice ( Supplementary  Fig. 3d ). Similar to that seen after chemical inhibition of the proteasome, we found that cold adaptation led to higher expression of genes involved in stress pathways in the BAT of Nfe2l1 ∆BAT mice, whereas the BAT of WT littermates showed no stress response to cold (Fig. 2j) . Acclimating mice from 22 °C to 30 °C alleviated the activation of stress pathways in the Nfe2l1 ∆BAT mice, showing the reversibility and adaptive nature of this response (Supplementary Fig. 3e ). In addition, we observed perturbations in ER morphology and increased levels of heat shock proteins and autophagy in the BAT from Nfe2l1 ∆BAT mice as compared to that in the BAT from WT control mice ( Supplementary  Fig. 4) . To evaluate the role of Nrf1-mediated proteasome function in BAT for whole-body respiration, we used Nfe2l1 ∆BAT mice and control littermates that were born at thermoneutrality, placed at 22 °C and then treated with a low dose of bortezomib. In these experiments, Nfe2l1 ∆BAT mice were uniquely sensitive to proteasome inhibition, as only Nfe2l1 ∆BAT mice showed an unrecoverable bortezomib-induced drop in respiration, whereas WT mice fully recovered after the same kind of treatment (Fig. 2k) .
BAT activity requires Nrf1 for metabolic adaptation Although the BAT in Nfe2l1 ∆BAT mice seemed grossly normal at birth, when the mice were raised at 22 °C, the tissue became progressively discolored and lipid-laden and appeared white in adult mice, as compared to that seen in the BAT of the WT littermates (Fig. 3a,b and Supplementary Fig. 5a ). In line with the concept that Nrf1 and proteasome function are dispensable at thermoneutrality, the BAT of Nfe2l1 ∆BAT mice and WT littermates born and raised at 30 °C was indistinguishable (Supplementary Fig. 5b-d) . Notably, neither changes Ucp1 protein levels ( Supplementary Fig. 3b,c) nor changes in mRNA levels of genes encoding critical brown adipocyte regulators, such as Ucp1, Ppargc1a, Ppargc1b, Ppara or Pparg, were detected in the BAT of the two genotypes, either at 30 °C or at 22 °C ( Supplementary  Fig. 5e ). However, consistent with the results described above (Fig. 2j) , ER stress, as measured by Ddit3 expression, was increased at 22 °C but not at 30 °C in Nfe2l1 ∆BAT mice (Supplementary Fig. 5e ). Notably, BAT-mediated whole-body respiration was lower in Nfe2l1 ∆BAT mice that were raised at 22 °C than in the WT control mice at 22 °C, but not at 30 °C (Supplementary Fig. 5f ).
To characterize the metabolic activity of Nrf1-deficient BAT, we investigated the ability of Nfe2l1 ∆BAT mice that were reared at 22 °C to metabolize triglyceride-rich lipoproteins, a major substrate for BAT activity 2 . Using a novel imaging platform with shortwave infrared (SWIR)-emitting quantum dots 38 , we observed that although there was a pronounced uptake of lipoproteins in cold-activated BAT of WT mice, the BAT of Nfe2l1 ∆BAT mice did not display any detectable uptake of lipoproteins (Fig. 3c,d and Supplementary Videos 1 and 2). Consistent with the discoloration observed, the abnormal BAT in Nfe2l1 ∆BAT mice that were reared at 22 °C was characterized by lower iron and mitochondrial content (Fig. 3e,f) . Using transmission electron microscopy, we observed that the mitochondria in brown adipocytes of Nfe2l1 ∆BAT mice displayed abnormal shape, irregular cristae organization and signs of mitochondria-associated membrane (MAM) formation, as compared to the mitochondria in the BAT of WT littermates (Fig. 3g) . Furthermore, similar to that observed after chemical inhibition of the proteasome, isolated mitochondria from BAT of Nfe2l1 ∆BAT mice were characterized by lower state 3, oligomycin-resistant (state 4), maximal respiratory capacity, as well as GDP-sensitive Ucp1-dependent respiration than that in mitochondria isolated from WT controls (Fig. 3h,i and Supplementary Fig. 5g ). However, neither chemical inhibition of the proteasome nor Nrf1 deficiency was associated with reduced protein levels of components of the respiratory chain in isolated mitochondria per se (Supplementary Fig. 6a) .
To evaluate the effect of impaired BAT function on systemic metabolism in Nfe2l1 ∆BAT mice, we determined the effect of well-established BAT activators 25 on metabolic parameters in Nfe2l1 ∆BAT and control mice. Stimulation of whole-body oxygen consumption by treatment with norepinephrine (NE), a major physiological BAT activator, was markedly diminished in Nfe2l1 ∆BAT mice (Fig. 3j) . In line with this, CL-stimulated energy expenditure was lower in Nfe2l1 ∆BAT mice than in WT controls (Fig. 3k) . However, lipolysis in BAT and WAT explants remained unchanged by Nfe2l1 deletion (Supplementary Fig. 6b,c) . Although these results were obtained in mice that had been adapted to 22 °C, we also tested whether-for mice that had been reared at 30 °C-Nrf1 was required for the adaptation to chronic pharmacological BAT activation with CL in the absence of cold stress. BAT from saline-treated Nfe2l1 ∆BAT mice and WT littermates reared at 30 °C was histologically indistinguishable (Fig. 3l,m) . BAT from WT mice showed the expected CL-induced lipid depletion as compared to that in saline-treated WT controls, indicating BAT activation 4 . BAT from CL-treated Nfe2l1 ∆BAT mice showed a diminished, if not an opposite phenotype, as compared to that in BAT from WT mice treated with CL ( Fig. 3l,m) . In addition, CL-induced browning of IngWAT in WT controls was diminished in Nfe2l1 ∆BAT mice (Fig. 3n,o) , supporting the concept that thermogenic adipocyte activation itself rather than cold is required and sufficient for the Nfe2l1 ∆BAT phenotype to emerge.
Although our results consistently indicated BAT dysfunction in Nfe2l1 ∆BAT mice, we did not observe general cold intolerance inNfe2l1 ∆BAT mice, likely due to thermoregulatory compensation by lower peripheral heat loss (Supplementary Fig. 6d ). To further validate the inducible and adaptive nature of the Nrf1-proteasome pathway, as well as to rule out potential developmental defects in the Nfe2l1 ∆BAT model, we used a second mouse model in which the Nfe2l1 gene was inactivated with a tamoxifen-inducible Cre recombinase in adult mice housed at 22 °C. Similar to the constitutive Nfe2l1 ∆BAT model, Nrf1 was required to sustain mRNA levels of genes encoding proteasome subunits in the BAT (Supplementary Fig. 6e ) and to limit activation of cellular stress pathways ( Supplementary  Fig. 6f ). Within 1 week after the first tamoxifen injection, deletion of Nfe2l1 in adult mice led to abnormal macroscopic and histological appearance of BAT ( Supplementary Fig. 6g ), as well as diminished BAT-mediated whole-body respiration (Supplementary Fig. 6h ). 
The BAT ubiquitome
We next sought to identify the cellular pathways that are linked to Nrf1 and proteasome function in BAT. Proteasomal degradation of proteins requires their posttranslational modification with ubiquitin 39 , particularly formation of Lys48 (K48)-linked ubiquitin chains 40 , and conversely, insufficient proteasomal activity is linked to accumulation of K48-modified proteins 41, 42 . Because Nrf1 was critical for coldinduced proteasomal activity, we tested whether Nrf1 modulated the levels of ubiquitinated proteins in BAT. The quantity of ubiquitinated proteins in BAT was equivalent in WT and Nfe2l1 ∆BAT littermates when housed at 30 °C; however, the BAT of WT mice that were housed at 22 °C had higher levels of ubiquitinated proteins than the BAT of WT mice that were housed at 30 °C, and the BAT from Nfe2l1 ∆BAT mice had even higher levels of ubiquitinated proteins than that (Fig. 4a) . To identify the ubiquitinated proteins that were differentially modulated by cold adaptation in the setting of an Nrf1 deficiency, we performed a systematic and quantitative analysis of ubiquitinated proteins using multiplexed quantitative mass spectrometry (MS) 41 in the BAT of WT and Nfe2l1 ∆BAT mice. Consistent with the results described above (Fig. 4a) , this MS-based quantification confirmed the higher abundance of ubiquitinated proteins in BAT from the Nfe2l1 ∆BAT mice as compared to that in the WT controls (Fig. 4b) . Ubiquitin linkages are formed by one of seven lysine residues in ubiquitin 40 . K48 modification was the most abundant ubiquitin linkage identified in the BAT samples and accounted for ~63% of all modifications; this was followed by K6 (~15%) and K63 (~10%) linkages ( Supplementary Fig. 7a and Supplementary Table 1) . K48, K11 and K708 ubiquitin linkages, which have been previously linked to ERADselective proteasomal degradation 40 , were all higher in Nfe2l1 ∆BAT mice compared to those in WT controls (Fig. 4b) . In contrast, putative nondegradative, regulatory linkages such as K27, K29 and K63 (ref. 40) were unchanged in Nfe2l1 ∆BAT mice. Because insufficient proteasomal activity might alter the abundance of specific proteins or because we detected higher ubiquitination simply due to high abundance of the proteins we found, we normalized the amount of ubiquitination for each identified lysine residue to the amount of the respective protein, as determined by conventional proteomics analysis. This allowed determination of the ubiquitination status of each identified protein independently of the actual protein amount. In the analysis of this differential ubiquitome, we found that Nrf1 deficiency led to greater ubiquitination of proteins ( Fig. 4c and Supplementary Table 2 ) and indicated that the BAT of Nfe2l1 ∆BAT mice was in a hyper-ubiquitinated state. Remarkably, ~34% (418/1,229) of all hyper-ubiquitinated sites in BAT of Nfe2l1 ∆BAT mice were listed in the Mitocarta (Fig. 4c) , a proteomic inventory of mitochondria 43 , including components of the respiratory chain, as well as Ucp1 (Fig. 4c) , which has been described earlier to be regulated by proteasomal degradation 44 . Next, to investigate whether, in addition to mitochondrial proteins, other specific cellular processes were overrepresented in the hyper-ubiquitinated state of Nrf1 deficiency, we performed unbiased computational gene set enrichment analysis (GSEA) 45, 46 of the major hyper-ubiquitinated proteins. We found that 27 processes were represented by 228 hyper-ubiquitinated proteins (Fig. 4d) and that these were most notably related to mitochondria and organelle homeostasis, in particular to ER proteins and energy metabolism ( Supplementary Fig. 7b and Supplementary Table 3) . We expanded our analysis to identify functional clusters in these processes using the ConsensusPathDB (CPDB) interaction database 47 and found that respiration and lipid metabolism were most notably represented in the hyper-ubiquitinated state (Supplementary Fig. 7c ). Using CPDB we also explored whether the major hyper-ubiquitinated proteins belonged to functional complexes and found, among others, the respiratory chain, pyruvate dehydrogenase and the ER folding machinery (Fig. 4e) . Taken together, these data demonstrate that Nrf1 is a critical regulator of brown adipocyte proteome health, enabling the proper turnover of ubiquitinated proteins. In addition, these results indicate that the thermogenic machineries for energy metabolism and respiration are particularly sensitive to imbalances in proteasomal activity and that cold adaptation requires efficient turnover of mitochondrial proteins.
BAT proteasomal activity is impaired in obesity BAT thermogenic activation exerts beneficial effects on systemic metabolism [2] [3] [4] , but chronic obesity results in reduced metabolic capacity of BAT in mice 11 . Because it is not known whether proteasomal activity is altered and linked to the metabolic response to HFD-induced obesity (DIO), we investigated the relevance of Nrf1-mediated proteasomal activity in thermogenic adipocytes for obesity and associated metabolic dysfunction. First, we measured proteasomal activity in the BAT of lean or HFD-fed WT and Nfe2l1 ∆BAT mice at 22 °C. We found that in the BAT of WT mice, chemotrypsin-like and caspase-like proteasomal activities were specifically lower in DIO and that this effect was amplified in the BAT of Nfe2l1 ∆BAT mice in both lean and obese conditions (Fig. 5a) . In lean mice that were housed at 22 °C and fed a regular chow diet, we did not find differences in body weight or glucose tolerance between Nfe2l1 ∆BAT mice and WT controls ( Supplementary Fig. 8a,b) . However, Nfe2l1 ∆BAT mice that were fed a HFD gained more weight and displayed higher adiposity as compared to their WT littermates that were fed a HFD (Fig. 5b) . Under these conditions, Nfe2l1 ∆BAT mice showed impaired glucose tolerance and insulin resistance (Fig. 5c,d) , which was also reflected in higher plasma insulin and leptin concentrations as compared to those in the WT controls (Supplementary Table 4) . Concentrations of adiponectin, triglycerides, cholesterol and transaminase in the blood were unchanged between genotypes (Supplementary Table 4) .
In addition to higher lipid accumulation as compared to that in the WT controls on a HFD, we observed adipose tissue inflammation in the BAT from Nfe2l1 ∆BAT mice, as indicated by abundant crown-like structures (Fig. 5e) resulting from inflammatory immune cell infiltration, similar to what has previously been described exclusively in WAT from obese animals 48, 49 . We confirmed the higher amount of macrophage infiltration in the BAT of Nfe2l1 ∆BAT mice, as compared to that in the WT controls, by flow cytometry analysis ( Fig. 5f and Supplementary Fig. 8c ), which also indicated a more proinflammatory polarization 50 in the BAT of Nfe2l1 ∆BAT mice as compared to that in the BAT of WT controls ( Fig. 5g and Supplementary  Fig. 8c ). Consistent with this observation, short-term inhibition of the proteasome in cultured brown adipocytes led to higher expression of genes encoding several chemokines and pro-inflammatory cytokines, as compared to that in vehicle-treated cells (Supplementary Fig. 8d) , which was heightened in the absence of Nrf1 in vivo ( Supplementary  Fig. 8e ). This indicates that adipocyte stress in the setting of an Nrf1 deficiency or after proteasome inhibition induces the expression of chemokines, which could explain the strong immune cell infiltration observed in vivo. As compared to the WT controls, Nfe2l1 ∆BAT mice also had higher plasma concentrations of several proinflammatory cytokines, including TNF-α, an important mediator that links adipose tissue inflammation to insulin resistance 51 ( Fig. 5h and Supplementary Table 4 ).
Enhancing proteostasis in BAT alleviates insulin resistance Finally, to address the reversibility of the effect of a genetic Nrf1 deficiency, as well as to examine the potential metabolic benefits of enhancing Nrf1 function in adult mice, we used an intra-tissue adenovirus (AV)-injection strategy to drive Nfe2l1 overexpression in BAT. First, injection of an AV expressing Nrf1 (AV-Nrf1) into the BAT of lean Nfe2l1 ∆BAT mice led to higher expression of Nfe2l1 mRNA and Nrf1 in the BAT, as well as of Psma1 and Psmb1, as compared to that in the contralateral side of the interscapular BAT depot of the same mice, which was injected with a control AV that expressed β-galactosidase (AV-LacZ) (Fig. 6a,b and Supplementary Fig. 9a ). Re-expression of Nrf1 in the BAT of Nfe2l1 ∆BAT mice partially restored proteasomal activity, as compared to that in AV-LacZ-injected WT mice (Fig. 6c) . WT mice injected with AV-Nrf1 also showed moderately higher chemotrypsin-like activity relative to that in AV-LacZ-injected contralateral BAT (Fig. 6c) . Nrf1 re-expression in the BAT of Nfe2l1 ∆BAT mice induced a more brown-like phenotype, as observed on the basis of appearance (Fig. 6d) , histology ( Fig. 6e) and Ucp1-specific immunohistochemistry (IHC), as compared to that observed in the contralateral side (Fig. 6f) . Immunoblot analysis, however, indicated similar total Ucp1 levels between the groups (Supplementary Fig. 9a ). To explore whether these changes in the BAT of Nfe2l1 ∆BAT mice treated with AV-Nrf1 translated into changes in BAT metabolic activity, we performed a combined oral glucose and fat tolerance test with radiolabeled glucose and fatty acid tracers 2 . Re-expression of Nrf1 in the BAT of Nfe2l1 ∆BAT mice partially restored fatty acid uptake and completely rescued glucose uptake as compared to that in AV-LacZ-injected WT controls (Fig. 6g) .
To address the translational relevance of Nrf1 targeting, we next tested whether increasing Nrf1 activity in the BAT of mice with obesity-associated insulin resistance might enhance proteasome function and thus confer beneficial systemic metabolic effects. Therefore, we evaluated the effects of AV-Nrf1 delivery into the BAT of WT mice with HFD-induced obesity (Fig. 6h) . As expected, Nfe2l1 mRNA levels and proteasomal activity were higher after treatment with AVNrf1 in DIO mice as compared to that in AV-LacZ-injected DIO mice (Fig. 6i,j) , which led to a body-weight-independent improvement of insulin tolerance just 9 d after AV-Nrf1 injection, as compared to that in AV-LacZ-injected mice (Fig. 6k and Supplementary Table 5) . We further validated the beneficial effect of AV-Nrf1 injection into BAT in an independent model of obesity, insulin resistance and associated disorders, the leptin-deficient ob/ob mouse 52 . We found that AV-Nrf1 treatment improved insulin tolerance independently of body weight or Ucp1 levels in BAT, as compared to that in AV-LacZ-injected ob/ob mice ( Supplementary Fig. 9b-d and Supplementary Table 5) .
To prove that proteostasis per se was a critical aspect of BAT adaptation and had therapeutic relevance, we designed an Nrf1-independent strategy targeting proteasome function. To this end, we used a similar intraBAT adenovirus injection strategy to deliver PA28α (encoded by Psme1), a regulatory component of the proteasome that enhances its activity 53 , into the BAT of DIO mice (Fig. 6l) . We found that injection with AV-PA28α led to higher mRNA expression of Psme1 in BAT (Fig. 6m) and higher BAT proteasomal activity, as compared to that in AV-LacZ-injected mice (Fig. 6n) . Similar to the effects of AV-Nrf1 injection in this model (Fig. 6h-k) , PA28α expression improved insulin tolerance as compared to that in LacZ-expressing control mice, independently of body weight (Fig. 6o and Supplementary Table 5) . Finally, we independently validated the effects of AV-PA28α delivery into BAT of ob/ob mice (Fig. 6p) , which led to higher expression of Psme1 and proteasomal activity in the BAT (Fig. 6q,r) , as well as improved insulin tolerance of the mice, as compared to that in the AVLacZ-injected ob/ob mice ( Fig. 6s and Supplementary Table 5 ).
DISCUSSION ER homeostasis is a critical component of metabolic health, especially in the context of obesity 18 . However, the mechanisms that protect the ER from metabolic stress in adipocytes remain unclear. Moreover, although thermogenic fat cells possess exceptional metabolic properties, which account for ~65% of total oxidative metabolism in mice when fully recruited 1 , it is unclear whether brown adipocytes require specific mechanisms to mitigate cellular stress in this state of high metabolism. Here we find that cold adaptation of brown fat requires proteasomal activity, which is transcriptionally driven by cold-inducible Nrf1. In this way, Nrf1 in thermogenic fat cells is a metabolic guardian, preventing tissue stress and inflammation independently of BAT differentiation, mass or expandability.
One could argue that the phenotypes associated with Nrf1 deficiency in BAT are simply a reflection of a defect in a fundamental process, which compromises the general integrity of the tissue. However, several lines of observations make this possibility very unlikely. First, genetic deletion of Nrf1 expression in BAT does not result in complete proteasome deficiency; it only limits the inducible component of proteasomal activity required for thermogenic adaptation. Second, the effects of proteasome inhibitors on nonshivering thermogenesis in mice are not associated with changes in Ucp1 levels, BAT mass or histological appearance. Third, we do not find any effect of Nrf1 deficiency on key brown-fat regulators such as Ucp1, Pgc1-α, Pgc1-β, Pparg-α or Pparg-γ. Fourth, mice lacking Nrf1 in brown adipocytes are born normal, but alterations in the BAT of Nfe2l1 ∆BAT develop as a function of cold and age. At thermoneutrality, where BAT activity is minimal, Nrf1 levels in BAT are very low, and in this environment neither proteasome inhibition nor genetic deficiency of Nrf1 are deleterious for the tissue, indicating that the Nrf1-mediated program is not vital in BAT but rather is required for adapting to rising thermogenic activity. This is further corroborated by the phenotype of tamoxifen-induced deletion of Nrf1 expression in adult mice. Indeed, BAT thermogenic activation following cold adaptation or treatment with the β3-agonist CL at thermoneutrality requires an Nrf1-mediated increase in proteasomal activity to fulfil its metabolic potential.
In many tissues, metabolic or proteotoxic stress is combatted by the activation of classical UPR pathways. Our finding that proteasome-mediated degradation of proteins contributes more to the metabolic function of brown adipocytes than chaperone-assisted protein folding (exemplified here by the Ire1-Xbp1 pathway) might be partially related to a limited expandability and folding capacity of the ER in brown adipocytes. Indeed, in Nfe2l1 ∆BAT mice we observed a compensatory response to the failure of the UPS to keep pace with proteometabolic demand during cold adaptation, which altogether was unable to restore ER homeostasis in the absence of sufficient proteasomal activity. Of note, this process was partially reversible, as moving Nfe2l1 ∆BAT mice from colder to warmer temperatures alleviated stress responses in BAT, further supporting that the regulation of proteasomal activity by Nrf1 serves as a physiological adaptation to high metabolism associated with thermogenic BAT activity.
On the basis of evidence from cultured cells, it is well accepted that proteasome-mediated degradation of proteins is important for clearing damaged or dispensable proteins 16 , but little is known about the plasticity 
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∆BAT AV-LacZ Nfe2l1 ∆BAT AV-LacZ and physiological relevance of this process. Indeed, the proteasome is often considered a static protein complex, and most mechanistic investigations have been performed with chemical inhibitors 27, 31, 32 . In this context, our finding that cold adaptation naturally engages the UPS through Nrf1 is a remarkable example of physiologically stimulated proteasomal protein degradation. We also found that in the general absence of phenotypic abnormalities in Nfe2l1 ∆BAT mice born at thermoneutrality, Nrf1 in BAT was still required to cope with proteotoxic stress induced by proteasome inhibitors after the tissue was activated by cold. This further emphasizes the adaptive role of and mechanistic link between Nrf1, the proteasome and nonshivering thermogenesis. Notably, even though Nrf1 is ubiquitously expressed in cells and tissues, regulation of its expression and activation, as well as downstream mechanisms engaged by Nrf1, are poorly understood. The marked cold-induced increase in Nrf1 is specific for brown and beige adipocytes, which possibly indicates a cell-type specific regulation of Nfe2l1 gene expression. Although in the liver Nrf1 and proteasomal function have been linked to feeding and steatosis 20, 54, 55 , there was no induction of proteasomal activity by cold in this tissue. Our study globally identifies proteins and cellular pathways modulated by the Nrf1-proteasome pathway, suggesting that proteasomal protein turnover is a prerequisite for cold-induced metabolic activity and remodeling of BAT. Beyond the role of the Nrf1-proteasome pathway in maintaining ER homeostasis, we found that the hyper-ubiquitinated proteins in the BAT of Nfe2l1 ∆BAT mice represented a broad array of brown fat metabolic processes that ranged from carbohydrate to lipid metabolism and that, unexpectedly, included a large number of mitochondrial proteins. This is directly linked to mitochondrial respiratory capacity in terms of oxidative substrate turnover, leak respiration and Ucp1 function. In addition to enhanced ubiquitination of general mitochondrial components, here we discovered ubiquitination of numerous known regulators of nonshivering thermogenesis, as well as other proteins with unknown function in BAT, which taken together emphasize the fundamental role of Nrf1-mediated proteasomal activity for proteostasis and metabolic quality control in BAT. In conjunction with earlier reports on Ucp1 ubiquitination 44 , our study identifying numerous cold-regulated ubiquitination sites provides the biochemical basis for understanding the turnover of BAT proteins in response to cold adaptation. An important question that emerges from our study is how the Nrf1-proteasome pathway might relate to obesity and associated diseases in humans. A recent epigenome-wide association study linked altered methylation of the human NFE2L1 locus to BMI and adverse outcomes of obesity 56 , although future mechanistic studies are needed to understand how this epigenetic variant might affect Nrf1 and proteasome activity. Additionally, we demonstrated here that there were high levels of NFE2L1 expression in human BAT, which correlated with brown functionality of human clonal adipocyte cell lines or tissue samples. Moreover, in mice we found that proteasomal activity in BAT was compromised in DIO and that Nrf1-mediated proteasomal activity was required to maintain ER homeostasis and limit the activation of cellular stress pathways, tissue inflammation and obesity-induced metabolic dysfunction (Supplementary Fig. 10) . In exploring the translational potential of the Nrf1-proteasome pathway, we found that increasing proteasomal activity by adenovirus-mediated expression of Nrf1 or the proteasome activator PA28α into BAT of mice with dietary or genetic obesity resulted in improved systemic insulin sensitivity and glucose homeostasis. In addition, these experiments suggest that other proteolytic, ubiquitin-independent cellular machineries might also be part of global proteostatic regulation in BAT, which opens possible future avenues for further exploration of their role in metabolic regulation.
An important consideration for future studies is the development of Nrf1-targeted therapies. We found that cold induced Nrf1 expression at both the mRNA and protein levels, and although the cleavage ratio of Nrf1 protein was unchanged, this overall increase produced higher levels of the active form. Hence, identification of this physiological signal mechanism governing Nrf1 expression or of factors that lead to more active Nrf1 protein will be interesting future avenues. Additionally, Nrf1 exhibits several features that, to our knowledge, do not exist in most other transcriptional regulators, which may offer multiple options for therapeutic targeting. For example, in addition to raising Nrf1 abundance to generate therapeutic efficacy as shown in our study here, Nrf1 has a multitude of posttranslational regulatory stages that are involved in mobilizing Nrf1 from the ER to the nucleus, which includes proteolysis, glycosylation, and potentially phosphorylation and ubiquitination 27, 31, 32, 57 . In addition, we have recently shown that cholesterol in the ER membrane of hepatocytes influences the transcriptional activity of Nrf1 (ref. 58 ). This multitude of regulatory stages will likely be accessible to a variety of modern-day therapeutic modalities. In fact, others have identified natural compounds that can also modulate Nrf1 (refs. 59,60), but their specificity and in vivo efficacy for obesity and related metabolic disorders remains unexplored.
Taken together, our evidence demonstrates that proteostasis and brown adipocyte health are critical to secure systemic metabolic integrity during states of high activity. This represents an important conceptual advance, as currently there is scarce understanding of the pathways that sustain the high metabolic demands imposed on BAT during thermogenesis relative to those involved in BAT activation or development. Furthermore, our study introduces the concept that Nrf1 is a fundamental adaptive regulator of brown adipocyte thermogenic function and may function as a general cellular guardian of metabolic health in obesity and beyond.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
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Mice and treatments. This section is also summarized in the Life Sciences Reporting Summary. Additional experimental details can be found in the Supplementary Methods. All experimental procedures involving animals were approved by the Harvard T.H. Chan School of Public Health (HSPH) Institutional Animal Care and Use Committee or in accordance with approved institutional protocols of the Massachusetts Institute of Technology. We purchased WT C57BL/6J mice (stock no. 000664), C57BL/6J HFD-DIO mice (stock no. 380050) and Lep ob (ob/ob) mice (stock no. 000632) from the Jackson Laboratories (Jax). Adipocyte-specific (Adipoq-Cre) Xbp1-deficient mice have been described previously 23 . LoxP-flanked (floxed) Ern1 (encoding Ire1-α) mice were provided by T. Iwawaki (Gunma University, Japan) and crossed with Adipoq-Cre mice (Jax stock no. 024671) to yield adipocyte-specific Ire1-α-deficient mice. We generated mice carrying floxed alleles of Nfe2l1 from Nfe2l1 tm1a(EUCOMM)Hmgu embryonic stem (ES) cells (International Mouse Phenotyping Consortium; http://www.mousephenotype.org/). In cooperation with the Harvard Stem Cell Institute, C57BL/6N-A/a ES cells were injected into blastocysts, giving rise to chimeric mice, of which males were continuously bred until germline transmission was successful in producing founders carrying the Nfe2l1 tm1a allele. This allele caused a whole-body null gene with Flp recombinase sites that could be used to re-insert the WT allele containing Cre recombinase sites surrounding exons 4 and 5. This locus includes the coding region for the DNA-binding domain of Nrf1. We bred mice with C57BL/6J Flp recombinase transgenic mice (Jax), after which the Flp transgene was bred out, leaving mice with only the floxed Nfe2l1 allele. These were crossed with hemizygous transgenic mice expressing Cre under the control of the Ucp1 promoter (Ucp1-Cre) 61 or with hemizygous mice expressing tamoxifen-inducible Cre under control of the chicken β-actin promoter-enhancer coupled with the cytomegalovirus (CMV) immediate-early enhancer (CAGGCre-ER TM ; Jax stock no. 004682), which allowed for conditional deletion of Nrf1 expression. After backcrossing with C57BL/6J mice, we used homozygous floxed Nfe2l1 alleles with Ucp1-Cre (Nfe2l1 ∆BAT mice) and WT control littermates carrying floxed Nfe2l1 alleles but no Cre or CAGGCre-ER TM (Ind.Nfe2l1 −/− ) and WT littermates, respectively. We performed genotyping by PCR or Transnetyx (Supplementary Table 6 ). Unless indicated otherwise, mice were bred and housed in the HSPH animal facility at 22 °C with ad libitum access to a standard laboratory chow diet (PicoLab Mouse Diet 20 5058, LabDiet) and a 12 h light/dark cycle. We induced obesity by feeding mice a HFD ad libitum beginning at 6 weeks of age for 16 weeks, before assessment of metabolic disease (D12492i, Research Diets) in three independent cohorts of mice. We bred and/or housed (7 d) thermoneutral mice in a Memmert HPP750 LIFE Chamber at 30 °C with ad libitum access to a standard laboratory chow diet (PicoLab Mouse Diet 20 5053, LabDiet) and a 12 h light/dark cycle. For cold adaptation (4 °C for 7 d) we housed mice in single cages with ad libitum access to a standard laboratory chow diet (PicoLab Mouse Diet 20 5058, LabDiet) and a 12 h light/dark cycle. We used 12-week-old male mice unless indicated otherwise. No blinding was performed. Sample size was estimated by pilot experiments that showed trends of effects and their sizes. In most cases, an n = 6 was the minimum number of mice used; in cases where the size of the effect was large, an n = 4 yielded significant results. Mice were excluded for poor body condition (for example, after surgery or during feeding studies). We randomly used age-matched littermates for the study of adult mice. We performed glucose tolerance tests after 16 h of fasting by intraperitoneal injection of 1 g/kg glucose in PBS. We performed insulin tolerance tests after 6 h of fasting by intraperitoneal injection of 0.75 U/kg (DIO mice) or 1.25 U/kg (ob/ob mice) insulin (Eli Lilly Humulin) in 0.2% wt/vol BSA in PBS. We combined oral glucose and fat tolerance tests by gavage of a mixture of liposomes containing 6.17 KBq [9,10-3 H(N)]-triolein per g body weight and glucose (1 g/kg body weight) traced with 0.12 KBq 2-desoxy-D-[ 14 C]-glucose per g body weight in water as described previously 2 . We measured body composition in anesthetized (treated with 100 mg/kg ketamine and 10 mg/kg xylazine) mice with dual-energy X-ray absorptiometry (DEXA Lunar PIXImus, GE). We measured energy expenditure, respiration and activity using a Columbus Instruments' Oxymax Comprehensive Lab Animal Monitoring System (CLAMS) system according to guidelines for measuring energy metabolism in mice 62 . We measured BAT-mediated energy expenditure by subcutaneous injection of NE (Sigma, 1 mg/kg in 0.9% wt/vol NaCl) or CL316,243 (CL, Tocris, 0.5 mg/kg in 0.9% wt/vol in NaCl) according to guidelines for measuring BAT activity 25 at ~1:30 p.m. We performed chronic CL treatment by subcutaneous injection of CL (0.5 mg/kg) for 7 d in 8-week-old female mice. We injected bortezomib (Selleckchem, 2.5 mg/kg in 10% vol/vol DMSO in PBS) or 10% vol/vol DMSO in PBS (as vehicle) intraperitoneally at 5:00 p.m. and performed body core temperature measurements, mitochondrial isolation and necropsy of WT B6 mice 16 h later. To test the effect of bortezomib in WT and Nfe2l1 ∆BAT littermates, mice that were born and raised at 30 °C were transferred to 22 °C to the CLAMS system at 8 weeks of age, and after 72 h bortezomib (Selleckchem, 1.25 mg/kg in 10% vol/vol DMSO in PBS) or 10% vol/vol DMSO in PBS as vehicle were injected intraperitoneally. We injected carfilzomib (Selleckchem, 4 mg/kg in 33% vol/vol DMSO in H 2 O) or 33% vol/vol DMSO in water (as vehicle) into the tail vein of single-caged WT B6 mice at 10 a.m. and performed body core temperature measurements and necropsy 4 h and 6 h later, respectively. We measured rectal body core temperature using a Physitemp Thermalert TH-5 probe and BAT and skin temperature using a FLIR Infrared camera (we took the average of two sequential images to calculate BAT and skin temperature per individual mouse). We performed standardized necropsies after 4 h of fasting (approximately at noon). Mice were anesthetized with 300 mg/kg ketamine and 30 mg/kg xylazine in PBS, blood was withdrawn by cardiac puncture, and mice were perfused with either PBS containing 50 U/ml heparin, formalin (Fisher Scientific) or electron-microscopy-grade fixative (Electron Microscopy Science). Organs were harvested and immediately preserved in TRIzol (Invitrogen), formalin or electron-microscopy-grade fixative or were snap-frozen in liquid nitrogen and stored at −80 °C. All experiments were reproduced in independent cohorts at least twice.
Proteasomal activity. We used the Proteasome Activity Fluorometric Assay (UBP Bio) according to the manufacturer's instructions to measure chemotrypsin-like, trypsin-like and caspase-like activity. In each assay, for each sample we used MG132 (Sigma) controls to determine the specific proteasomal activity ∆(slope) over time.
Gene recombination and expression analysis. We detected Cre-mediated recombination of floxed Nfe2l1 alleles in genomic DNA by PCR (Supplementary Table 6 ). We disrupted cells or tissues in TRIzol (Invitrogen) using TissueLyser (Qiagen). We isolated total RNA using the NucleoSpin RNA II kit (Macherey & Nagel). We synthesized complementary DNA using the iScript RT Supermix kit (Bio-Rad). We performed quantitative real-time PCR in triplicate on a ViiA7 system (Applied Biosystems) using SYBR green and custom-made primer sets designed by the Roche Universal ProbeLibrary Assay Design Center and verified by in silico PCR (https://genome.ucsc.edu/cgi-bin/hgPcr) (Supplementary Table 6 ). We normalized gene-of-interest cycle thresholds (C t values) to expression levels of the housekeeping gene TATA-box-binding protein (Tbp) or that encoding the 18S rRNA (Rn18s) by the ∆∆C t method and displayed the results as absolute or relative copies per Tbp or Rn18s, or as relative expression normalized to experimental control groups.
Human data. This study followed the institutional guidelines of, and was approved by, the Human Studies Institutional Review Boards of Beth Israel Deaconess Medical Center and Joslin Diabetes Center. Details on procedures of human subject collection were described previously 63 . All subjects gave written informed consent before taking part in the study. Neck adipose tissue (carotid sheath) biopsies from ten different subjects were studied; four samples were used for primary cell culture and immortalization as described below, and all ten were used for microarray analysis as described below. Isolation of primary stromal vascular fraction (SVF) from human neck adipose tissue was described previously 63 . Owing to the limited amount of human BAT tissue collected from surgeries, we pooled adipose depots from the same subject to obtain sufficient numbers of SVF cells for primary culture, as well as for the immortalization procedure, as described previously 34 . We performed microarray analysis of gene expression using GeneChip PrimeView (Affymetrix, Santa Clara, CA) on paired white and brown adipose tissue biopsy samples from ten individuals, as well as from 42 highly adipogenic clones. RNA was isolated from tissue using Direct-zol RNA miniPrep kit (Zymo Research, Irvine, CA) according to the manufacturer's instructions. We evaluated the quality of total RNA by the A 260 / A 280 ratio, which was within the value of 1.9 to 2.0 (defined as high-quality total RNA). Biotin-labeled cRNA was synthesized, purified and fragmented using GeneChip 3IVT Express Kit (Affymetrix, Santa Clara, CA). We assessed integrity and fragmented cRNA by running aliquots on the Agilent 2100 Bioanalyzer before proceeding further. The high-quality cRNA met the following criteria: the A 260 /A 280 ratio was within the range of 1.9 to 2.0; the 28S/18S rRNA bands (from the gel) were crisp, and the intensity of the 28S band was roughly twice the intensity of the 18S band.
Protein isolation and immunoblot analysis. We lysed tissues in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 0.1% wt/vol SDS, 0.5% wt/vol sodium deoxycholate, 1% vol/vol Nonidet P40, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM NaVO 4 and 10 mM NaF) using the Tissue Lyser II (Qiagen). For each isolation process, we added fresh protease inhibitors (Sigma) in a 1:100 ratio. For isolation of proteins from adipose tissue, the supernatant was centrifuged until the supernatant was cleared from fat contaminants at 4 °C for 20 min at 13,000g. Protein lysates were stored at −20 °C until further use. Protein concentrations were determined using the Pierce BCA kit (Life Technologies) according to the manufacturer's instructions. For western blot analysis, we used lysates in a final concentration of 1 µg/µl in 50% vol/vol Laemmli buffer. 4-12% Bis-Tris gels (Life Technologies) with MES buffer were used for SDS-PAGE. After separation, proteins were transferred onto a nitrocellulose membrane (BioRad) using the wet blot technique (Bio-Rad) and blocked in 5% wt/vol milk; primary antibodies (Supplementary Table 6 ) were applied in 0.5% wt/vol milk overnight at 4 °C. After washing 4× for 15 min with TBS-T, secondary antibodies (Santa Cruz) were applied for 1 h in 5% w/v milk at room temperature. Then membranes were washed again 4× for 15 min in TBS-T and developed using Super Signal West Femto Maximum Sensitivity Substrate (Life Technologies) and a FluorChem M imager (proteinsimple). We analyzed immunoblot digital images with the software of the device. Uncropped images can be found in Supplementary Figures 11-13 .
Phenotypic endoplasmic reticulum (ER) reporter assay. We previously described the asialoglycoprotein receptor 1 (ASGR1)-Cypridina noctiluca luciferase (Cluc) fusion protein system to monitor ER protein folding that also expresses Gaussia luciferase (Gluc) as an internal control 29 . Here we used 3T3-L1 adipocytes that stably expressed the reporter system and performed the experiment as previously described 29 . We measured luciferase secretion after 4 h of incubation with the indicated compounds.
Primary cell preparation, genetic modification and culture. All cell culture experiments were reproduced at least twice. Representative data are shown for Seahorse and immunoblot analysis. We isolated primary preadipocytes from interscapular BAT of 6-week-old mice by the method of Rodbell 64 , which were cultured for 48 h and infected with lentivirus carrying the gene encoding human telomerase (hTERT). To generate a lentiviral construct expressing hTERT, we amplified the cDNA encoding hTERT (isoform 1 from pBABE-hTERT (Addgene plasmid 1771) with Q5 Taq polymerase (New England Biolabs) and primers to insert XbaI (5′) and SalI (3′) restriction sites) by PCR. We cloned hTERTencoding cDNA into the XbaI and SalI restriction sites of pLenti CMV GFP Hygro (Addgene plasmid 17446). We acquired mouse Nfe2l1 cDNA from Open Biosystems, as previously described 50 . We generated mammalian cell expression plasmids encoding hemagglutinin (HA)-tagged Nrf1 by performing an LR recombination reaction between pENTR1A and destination vector pLenti/ CMV/Puro-DEST using Gateway LR Clonase Enzyme Mix (Life Technologies, 11791-019). To generate lentivirus particles, we transfected 293T Lenti-X cells (Clontech) with second-generation packaging and envelope (psPAX2 and pMD2.G) and pLenti/CMV/Hygro/hTERT or pLenti/CMV/Puro/Nrf1 plasmids, respectively. Lentivirus-containing supernatant was collected at 48 h and 72 h after the initial transfection and filtered through a 0.45-µm syringe filters. The viral supernatant was diluted 1:2 with fresh Dulbecco's modified Eagle's medium (DMEM) and supplemented with 2 µg/ml polybrene before performing two rounds of infection on the preadipocytes. At 48 h after the final infection, the preadipocyte medium was changed to fresh DMEM containing 10% vol/vol FBS and penicillin-streptomycin. Selection with 125 µg/ml hygromycin B (Invitrogen) was performed for 2 weeks. For differentiation of preadipocytes into brown adipocytes, cells were induced for 2 d and differentiated for 4 d following 1 d of cultivation in standard maintenance medium, before conducting experiments. The composition of the differentiation medium was established by titrating the various compounds over time (data not shown). The induction medium was composed of DMEM with high glucose, 10% cosmic calf serum (CCS), 1% penicillin-streptomycin, 20 nM insulin, 2 nM triiodo-l-thyronine (T3), 150 µM ascorbate, 1 µM rosiglitazone, 500 µM 3-isobutyl-1-methylxanthine (IMBX) and 1 µM dexamethasone. Differentiation medium was made up of DMEM with high glucose, 10% CCS, 1% penicillin-streptomycin, 20 nM insulin, 2 nM T3, 150 µM ascorbate and 1 µM rosiglitazone. To ensure proper growth and adequate supply with nutrients, we changed the medium every 2 d.
Seahorse analysis of respiration in isolated mitochondria and in cells. We adhered to guidelines for assessing mitochondrial function 65, 66 . Mitochondria were purified as described previously 66 with modifications; all steps were performed at 4 °C. BAT from three or four WT littermate controls and from five or six Nfe2l1 ∆BAT 6-week-old mice or from four DMSO-treated and four bortezomib-treated WT mice were minced in a glass Petri dish containing 2 ml sucrose-Tris-EGTA (STE) buffer (250 mM sucrose, 5 mM Tris-HCl, 2 mM EGTA, pH 7.4) and then transferred to a 10-ml glass homogenizer with a Teflon pestle that contained 5 ml STE supplemented with 1% wt/vol FA-free BSA. These isolations and subsequent analysis were reproduced at least four times, and the data were pooled. Tissues were homogenized manually (up to six strokes), the volume was brought up to 25 ml, and the sample was centrifuged at 8,500g for 10 min. The top fat layer was removed, and the tube walls were wiped to remove excess fat. The pellet was resuspended in 1 ml BSA-free STE and transferred to a clean tube; the volume was brought up to 25 ml, and the sample was centrifuged at 800g for 5 min. The supernatant was collected and centrifuged at 8,500g for 10 min. The pellet was washed and resuspended in 150 µl STE. Protein concentration was determined by the BCA assay (Pierce). Respiration with 20 mM glycerol-3-phosphate as substrate 67 was measured in medium containing 50 mM KCl, 10 mM TES, 1 mM EGTA, 0.4% (wt/vol) FA-free BSA, 1 mM KH 2 PO4, 2 mM MgCl 2 and 0.46 mM CaCl 2 . The oxygen consumption rates were monitored in a Seahorse XF24 instrument at 2.5 µg mitochondrial protein per well. Baseline measurements (state 2) were performed with 1 mM ADP and 3 mM GDP, followed by injection of 20 mM glycerol-3-phosphate on port A and then 1 µg/ml oligomycin on port B. FCCP was titrated to 9 µM and injected on port C. Mitochondrial oxygen consumption was inhibited by the injection of 4 µM rotenone and 2 µM antimycin A on port D. GDP-sensitive respiration (Ucp1 activity) was calculated by subtracting basal uncoupled respiration in the presence of 20 mM glycerol-3-phosphate by the rates in the presence of 3 mM GDP plus 2% FA-free BSA. For Seahorse measurements in brown adipocytes, cells were seeded at 40,000 cells per well in a 24-well Seahorse V7 plate in two independent experiments. In order to ensure even distribution, cells were seeded in 100 µl of medium and kept for 1 h at room temperature, following 2 h at 37 °C. Then, 150 µl medium was added, and the cells were allowed to fully attach overnight. Epoxomicin (100 nM) was applied for 16 h with 150 µl medium, and the cells were incubated overnight. The corresponding amount of DMSO was added as a control treatment. On the day before the experiment, Seahorse cartridges with the sensors were equilibrated in XF calibrant solution at 37 °C in a non-CO 2 chamber overnight. Seahorse medium was always prepared fresh on the day of the experiment and was composed of XF base medium, 2% BSA, 25 mM glucose, 2 mM pyruvate and 2 mM l-glutamine. The pH was adjusted to 7.4 using 1 M NaOH, and the medium was filter-sterilized before applying it to cells. Cells were washed twice with 1 ml Seahorse medium before incubating them with 500 µl of Seahorse medium for 1 h at 37 °C without CO 2 , before the experiment. Concentrations of oligomycin and FCCP were determined by thorough titration (data not shown). Final concentrations were 2.5 µM oligomycin, 22 µM FCCP and 0.5 µM rotenone-antimycin A. The standard protocol was 3 min mix, 2 min wait and 3 min measure. For the normalization of respiration to live cell count after the measurement, cells were washed gently using 1× PBS, following fixation using 150 µl methanol for each well. After a 20-min incubation at room temperature, the cells were washed with 1× PBS. In order to stain DNA of cells, 25 µl of a 0.1% wt/vol crystal violet (Sigma) solution was applied on fixed cells, and the sample was incubated for 30 min at room temperature. The cells were then washed 3× with water, and the plate was allowed to air dry. For lysis, 25 µl of a 1% vol/vol Triton X-100 in PBS solution was applied. The plate was placed on a shaker for 15 min at room temperature. The lysate was diluted 1:5 with PBS, and the absorbance was measured 595 nm. Cell count was determined by using a standard curve of absorbance of defined cell numbers.
Mitochondrial iron and DNA measurement. For quantification of iron levels, we homogenized BAT samples from one cohort of mice in acid solution, and the iron content, as compared to a standard solution, was determined by inductively coupled plasma mass spectrometry (ICP-MS) on an Elan DRC-II machine (Perkin-Elmer). For mitochondrial DNA content analysis, we isolated total DNA from BAT by phenol-chloroform extraction and amplified mitochondrial, as well as nuclear, DNA by quantitative real-time PCR with SYBR green (Roche) as described previously 22 .
Lipolysis assay ex vivo. As described previsously 68 , we removed BAT and WAT depots from one representative cohort of 6-week-old littermates, minced them in DMEM with high glucose and washed them 5× with DMEM with high glucose supplemented with 2% wt/vol FA-free BSA (FA-free BSA DMEM, Sigma). We placed five or six pieces of adipose tissue into 12-well plates in 0.5 ml 2% wt/vol FA-free BSA DMEM and incubated them for 1 h at 37 °C before stimulation with 10 µM isoproterenol (Sigma). Samples were taken at the indicated time points, and 15 µl supernatant was assayed for non-esterified fatty acid (NEFA) concentrations. After the assay, we isolated DNA from the explants by phenolchloroform extraction, and the fatty acid release was normalized to DNA content.
Serum and plasma parameters. We measured glucose using the Bayer Breeze2 platform. We measured insulin with the Mouse Ultrasensitive Insulin ELISA kit (ALPCO), and adiponectin (Mouse Adiponectin/Acrp30 Quantikine ELISA Kit) and leptin (Mouse/Rat Leptin Quantikine ELISA Kit) were measured with R&D ELISA kits. Liver transaminases, triglycerides and cholesterol were determined using the Lipid Panel Plus Piccolo Xpress clinical chemistry platform (Abaxis). Cytokine concentrations were determined using the V-PLEX Proinflammatory Panel 1 (mouse) Kit (Mesoscale) according to instructions with undiluted plasma. We calculated HOMA-IR using the formula (Insulin[ng/ml]/0.0347) × glucose[mg/dl]/405. Adenoviral manipulation of gene expression in the BAT. We constructed the AV vector using the Adeasy system 69 with the full-length mouse 741 AS ORF of Nfe2l1 (Open Biosystems). Virus production was carried out by Vector Biolabs, and AV carrying the sequence encoding LacZ served as control particles (AVLacZ). AV infection was carried out by surgically accessing BAT while the mice were under anesthesia. The injections were reproduced in independent cohorts. For the infection of 8-week-old WT or Nfe2l1 ∆BAT mice, we locally injected 5 × 10 9 phage-forming units of AV-Nrf1 into the right side of iBAT, whereas the same amount of AV-LacZ particles were injected into the contralateral left side of the same mouse. For the infection of 24-week-old DIO mice, we injected 5 × 10 9 phage-forming units of AV-Nrf1 into each of the iBAT sides, whereas control mice received AV-LacZ into both iBAT sides. For the infection of 8-weekold ob/ob mice, we injected 5 × 10 9 phage-forming units of AV-Nrf1 into each of the iBAT sides, whereas control mice received AV-LacZ into both iBAT sides. We performed insulin tolerance tests 9 d, and necropsies 14 d, after surgery. AV carrying the sequence encoding PA28α was a kind gift from Xuejun Wang (University of South Dakota) and was produced and used as described above for AV-Nrf1; AV-LacZ served as a control for these experiments.
Statistical analyses. Data were expressed as mean ± s.e.m. Sample size was estimated by pilot experiments, which showed trends of effects and their sizes. In most of the cases for in vivo experiments in mice, an n = 6 was the minimum amount used; for cases in which the size of the effect was large, an n = 4 yielded significant results. A two-tailed, unpaired Student's t-test was used for pairwise comparison of genotypes or treatments, and a Holm-Sidak correction for multiple testing was used when appropriate, as indicated in the figure legends. For nonparametric comparisons, the Mann-Whitney U test was used. One-way ANOVA and two-ANOVA were used when comparing three or more groups, as indicated in the figure legends and otherwise. Analysis was performed using Microsoft Excel and/or GraphPad Prism. P < 0.05 was considered significant, as indicated by asterisks in the figures legends. Computational GSEA and CPDB analysis, which were done on the differential ubiquitome are described on the respective homepages (GSEA: http://www.broadinstitute.org/gsea; CPDB: http:// cpdb.molgen.mpg.de/MCPDB). Mice were excluded for poor body condition (for example, after surgery or during feeding studies, total n = 9 mice during HFD studies, n = 7 mice after surgery).
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For all flow cytometry data, confirm that:
1. The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
2. The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
3. All plots are contour plots with outliers or pseudocolor plots. Methodological details 5 . Describe the sample preparation. The interscapular BAT depot from individual mice was minced and incubated in DMEM containing collagenase I and II (Calbiochem, 2 mg/ml each) for 40 min at 37 °C with 120 rpm shaking. The reaction was stopped with FACS buffer (PBS containing 5% FBS) and the suspensions were filtered through 100 μm cell strainers (BD Falcon). The cell suspensions were centrifuged at 2500 rpm for 5 min. The pellet was re-suspended in FACS buffer and filtered with 40 μm cell strainer (BD Falcon). The cell suspension was centrifuged at 3500 rpm for 5 min and the pellet was incubated for 5 min in erythrocyte-lysing buffer (Sigma). Finally, the cells were suspended in FACS buffer. sorting was not performed 9. Describe the gating strategy used. After excluding the PI positive dead cell population, the live cell population was identified. Then, the macrophage population was identified as CD11b +F4/80+ cells. finally, M1-like cells were identified as CD11b+F4/80 +CD11chigh cells and M2-like cells were identified as CD11b+F4/80 +CD11clow cells
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